The store will not work correctly when cookies are disabled.
3-(1-(4-(4-methoxyphenyl)thiazol-2-yl)-3-methyl-1H-pyrazol-5-yl)-2H-chromen-2-one
ID: ALA4514120
PubChem CID: 129833343
Max Phase: Preclinical
Molecular Formula: C23H17N3O3S
Molecular Weight: 415.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2csc(-n3nc(C)cc3-c3cc4ccccc4oc3=O)n2)cc1
Standard InChI: InChI=1S/C23H17N3O3S/c1-14-11-20(18-12-16-5-3-4-6-21(16)29-22(18)27)26(25-14)23-24-19(13-30-23)15-7-9-17(28-2)10-8-15/h3-13H,1-2H3
Standard InChI Key: NAKSEEFOJVRTGP-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
2.4303 -32.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4292 -33.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1372 -34.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1354 -32.4502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8440 -32.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8474 -33.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5598 -34.0881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2734 -33.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2700 -32.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5530 -32.4377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9822 -34.0815 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9816 -32.4376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -32.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2741 -32.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8633 -31.4522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0646 -31.6247 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4582 -31.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5411 -30.2664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7935 -29.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2486 -30.5455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6595 -31.2518 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0894 -32.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7876 -29.1176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4961 -28.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4905 -27.8869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7779 -27.4818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0694 -27.9007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0785 -28.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7710 -26.6646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4752 -26.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
9 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
16 17 1 0
14 22 1 0
19 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
29 30 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.47 | Molecular Weight (Monoisotopic): 415.0991 | AlogP: 5.09 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.15 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.44 | CX LogP: 4.81 | CX LogD: 4.81 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.38 | Np Likeness Score: -1.35 |